This Act mandates federal health programs like Medicare and Medicaid to cover medically necessary specialized foods and formulas prescribed for managing severe digestive or inherited metabolic disorders.
James "Jim" McGovern
Representative
MA-2
The Medical Foods and Formulas Access Act of 2025 mandates federal health programs, including Medicare and Medicaid, to cover medically necessary specialized foods and formulas prescribed for managing severe digestive or inherited metabolic disorders. This ensures patients with conditions like urea cycle disorders or short bowel syndrome receive essential, prescribed nutrition when standard food is insufficient. The bill aims to standardize access to these life-sustaining treatments across federal and state health plans.
The Medical Foods and Formulas Access Act of 2025 is a big deal for thousands of families who rely on specialized nutrition just to stay alive. This bill mandates that major federal health programs—Medicare, Medicaid, and CHIP—must cover “medically necessary food” when prescribed by a doctor for specific inherited metabolic or severe digestive disorders. Think of this specialized food, which often comes as a liquid formula, not as a supplement, but as the actual treatment for conditions where the body can’t process regular protein, fats, or carbs. Without it, patients, especially kids, risk severe malnutrition, brain damage, and constant hospital stays, which the bill notes is a serious public health burden (SEC. 2. Findings).
This isn't about covering your daily vitamins or a gluten-free diet for celiac disease. The bill is laser-focused on life-or-death situations. “Medically necessary food” is defined as a specially formulated product—like a low-protein item or specific amino acids—prescribed for conditions where a person cannot properly digest or metabolize regular food (SEC. 3). The list of covered conditions includes serious inherited metabolic disorders (like urea cycle disorders) and severe digestive issues (like Crohn's disease that hasn't responded to standard treatment, or short bowel syndrome). The core idea is to close the gap where insurance covers drugs for these conditions but often balks at covering the necessary nutritional therapy, sometimes even forcing unnecessary feeding tube placement just to qualify for coverage. This bill aims to stop that.
For families currently paying thousands of dollars out-ofpocket for these specialty formulas—which can cost more than a mortgage—this is a massive financial relief. If you have a child with an inherited metabolic disorder, this coverage stabilizes their access to essential nutrition, reducing the risk of emergency room visits and developmental setbacks associated with formula shortages or coverage gaps. On the federal side, this coverage is phased in: Federal Employee Health Benefits (FEHBP) plans must comply in one year; CHIP plans in states must comply in one year; Medicaid must comply in two years; and Medicare Part B coverage kicks in after three years. For Medicare beneficiaries, the payment will be 80% of the cost, meaning the patient is still responsible for a 20% co-pay (SEC. 3. Medicare Payment Details).
While this bill is a huge win for patients with these specific, rare conditions, it’s important to note what it doesn’t cover. The bill explicitly excludes products marketed solely for general weight loss, managing diabetes, or standard gluten-free items (SEC. 3). While understandable that the bill focuses on the most critical needs, this exclusion could be an issue for patients with complex health profiles who rely on specialized nutritional products that fall into these gray areas. Another point of interest is that while the bill mandates coverage for federal programs, it hopes private insurers will follow suit, but doesn't force them to, unless they are the plans covering federal employees. Finally, the Secretary of Health and Human Services has the authority to add more conditions to the covered list later, giving the agency significant power over who qualifies for this essential coverage down the line (SEC. 3. Covered Diseases and Conditions).